US Patent granted, page-2

First 2 Last

Share
Profile

Follow
hangas75

2,656 Posts.

16/07/14

10:47

Post #: 13666250
Share

Originally posted by Kenny Powers ↑

PRIMA RECEIVES US PATENT GRANT FOR CVAC

SYDNEY, AUSTRALIA - Prima BioMed Ltd (ASX: PRR; NASDAQ: PBMD) ("Prima", the "Company") announces that the US patent number 8,771,701 titled "Compositions for immunotherapy and uses thereof", which protects the Company’s CVac™ technology, has been granted by the United States Patent and Trademark Office (USPTO).

Prima has also received a patent term adjustment of 1,409 days for US 8,771,701, extending the patent expiry date for the US market to August 2022.

Chief Executive Officer of Prima, Mr Marc Voigt said: "The grant of this key US patent with a patent term adjustment of almost four years is an important value proposition for Prima. The patent term can potentially be further extended by up to five years if CVac receives market approval before it expires, which would provide the Company with essential protection over its commercial development well into the future."
The patent grant protects the method of composition and the method of use of CVac, which is formulated in a patient’s own dendritic cells and then reinjected back into the patient to generate a cytotoxic T cell response against the mucin 1 antigen. CVac is a personalised immunotherapy composed of a patient’s own dendritic cells pulsed with the cancer antigen mucin 1, conjugated to oxidised mannan.
The patent grant follows receipt of the Notice of Allowance from the USPTO in relation to Patent Application 11/561,204 as announced on 26 May 2014. It completes the granting of all patents relevant to the CVac technology. Other territories that have received patent approval include Australia, Canada, Europe and Japan.

Expand

surely some sp appreciation now, is anybody out there looking for a bio prr has massive upside imo this stock should not be 4cnts.

PRR Price at posting: 4.0¢ Sentiment: Buy Disclosure: Held
8 Upvote

0 Great analysis

Reply

Top Stories

HotCopper Trends: Vection's $7M, Liontown dips & Wildcat PFS

EMD

Emyria Advances kicks off National Rollout with Avive Health Agreement

BEO

One of the biggest jumps today is the most obscure: Beonic Ltd up +65%

WC8

Wildcat’s PFS elicits lacklustre response

DUG

DUG Technology taking Shell to US District Court over A$4.75M dispute

First 2 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 27.0¢		Change 0.010(3.85%)		Mkt cap ! $396.3M

Open	High	Low	Value	Volume
27.5¢	27.5¢	26.5¢	$114.5K	420.5K

Buyers (Bids)

No.	Vol.	Price($)
23	229103	26.5¢

Sellers (Offers)

Price($)	Vol.	No.
27.0¢	164309	30

View Market Depth

No.	Vol.	Price($)
22	229047	0.265
16	337330	0.260
9	123397	0.255
18	381581	0.250
9	386358	0.245

Price($)	Vol.	No.
0.270	172062	32
0.275	435849	28
0.280	216802	13
0.285	122080	7
0.290	26500	4

Last trade - 14.08pm 29/07/2025 (20 minute delay)

IMM (ASX) Chart

US Patent granted, page-2

HotCopper Trends: Vection's $7M, Liontown dips & Wildcat PFS

Emyria Advances kicks off National Rollout with Avive Health Agreement

One of the biggest jumps today is the most obscure: Beonic Ltd up +65%

Wildcat’s PFS elicits lacklustre response

DUG Technology taking Shell to US District Court over A$4.75M dispute

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

US Patent granted, page-2

Top Stories

HotCopper Trends: Vection's $7M, Liontown dips & Wildcat PFS

Emyria Advances kicks off National Rollout with Avive Health Agreement

One of the biggest jumps today is the most obscure: Beonic Ltd up +65%

Wildcat’s PFS elicits lacklustre response

DUG Technology taking Shell to US District Court over A$4.75M dispute

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News